However, CD8+ DC were the major DC population depleted by CLL treatment, but not signficiantly by DT treatment (Fig 6D), so we used VACV to intradermally infect Batf3-/- mice, which lack CD8+ DC [60]. This evidence concerns the gene BATF3 and B-cell chronic lymphocytic leukemia.